Blog / Archives
Celgene (CELG) Down 5%-Take Profits
Celgene (CELG $162) is not on the Rayno biopharmaceutical focus list but it is a good candidate for hedging with a short position or profit taking. Goldman downgraded the stock today from Neutral...
Biotech Stocks: Flat Near Highs Since December 23
Steady As She Goes The IBB ($226) remains steady in the $225 range in quiet trading through the holiday period. The XBI ($130.69) shows a similar trend near its 52 week high. Fidelity Select Biotech...
Sierra SnowBlog-Grim Precip Outlook for West Coast Update 1/24/14 PDO
Update 12 N 1/23/14 Accuweather is sticking their umbrellas out calling for rain in San Francisco on Feb 4-but today downgraded that forecast. Unisys gives us nothing for six days.Same for...
Rayno Life Science Focus Stocks Part II-2013 Performance Diagnostics and Tools
New Products for Molecular and Companion Diagnostics Drive Growth Rayno Life Science Big Winners-ALR, CSII, ILMN,TMO A diversified life science portfolio must include clinical diagnostics and tools...
Rayno Life Science Focus Stocks: 2013 Performance-Biopharmaceuticals
Rayno Life Science Stock Picks Beat The Market Everybody now knows about the bull market in biotech stocks. Innovative products, favorable clinical news, M&A (see below) and breakthrough genomic...
Rayno Life Science-Early Movers With Holiday Rally
Santa Claus Making Fast Tracks Nasdaq is up 1% as of midday trading and life science stocks are strong across the board. The IBB is up 2.29%, XBI up 1.8 %.The holiday spirit pervades. Movers among...
FED Finesse-Steady As She Goes-Large Cap Biotechs Near Highs Update -1 PBYI
Taper Lite With Zero Interest Rates The big FED Meeting with the Bernanke farewell concluded with "taper lite", optimism on the economy and continued low inflation. The FED decision to roll back its...
Biotech Stocks Lagging In Today’s Rally
But A Lot of Green Today in Diagnostics and Tools The NASDAQ (4030)and the S&P (1787) are up about 0.7% but biotech stocks are lagging with the IBB ($216) up only 0.33%. Momentum in...
Many Biotech Momentum Stocks Are Selling Off: Technicals Rule
Biotech Bull Market Takes A Breather When the biotech bull market began in Q2 2009 it was value driven because of low technology values and Price/Sales for the widely covered stocks. Product sales...
Rayno Life Science Stocks-ASH Update-2 GILD, PCYC, SGEN
Weak Tape Today 12/10--Gilead (GILD) Down 4.4% on 15.5M Shares IBB ($218.81) down 1.33% on good volume. GILD fall could be reaction to Abbvie (ABBV $53.55) up 4.5% on Phase 3 Hepatitis C data....